Transducing signals from antigen receptors to nuclear factor kappaB

Immunological Reviews
Jürgen Ruland, Tak W Mak

Abstract

Signaling leading to the survival or apoptosis of immune system cells must be balanced to ensure the normal mounting and extinguishing of immune responses. One of the essential regulators of immune cell survival is the transcription factor nuclear factor kappaB (NF-kappaB). NF-kappaB is critical for the activation of T and B lymphocytes and is a central coordinator of innate and adaptive immunity. Pathogen recognition, whether mediated via the Toll-like receptors or via the antigen-specific T- and B-cell receptors, initiates the activation of distinct signal transduction pathways that activate NF-kappaB. Activation of NF-kappaB by these pathways is necessary for lymphocyte activation, expansion, and effector function in response to infection. In addition, recent work has shown that the aberrant activation of NF-kappaB by these pathways can contribute to the development of autoimmunity, chronic inflammation, or lymphoid malignancy. There is thus an urgent need to understand the exact molecular details of these signal transduction cascades so that we may develop novel therapeutics. This article will review the specific signal transduction pathways that mediate NF-kappaB activation in response to antigen receptor ligation in T and...Continue Reading

References

Jun 1, 1995·Current Opinion in Immunology·J JainA Rao
Aug 1, 1995·Seminars in Immunology·D J Rawlings, O N Witte
Aug 9, 1996·Science·M LeitgesA Tarakhovsky
Apr 1, 1997·Seminars in Cancer Biology·R M AttarR Bravo
May 23, 1998·Annual Review of Immunology·S GhoshE B Kopp
Aug 26, 1998·European Journal of Immunology·A AvrahamY Ben-Neriah
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·P S CostelloV L Tybulewicz
Apr 3, 1999·The Journal of Biological Chemistry·M YanV Dixit
May 27, 1999·Genes & Development·Q LiI M Verma
Jun 17, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·D J Rawlings
Oct 12, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S D DimitratosP J Bryant
Dec 22, 1999·Oncogene·B Rayet, C Gélinas
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·N CoudronniereA Altman
May 17, 2000·The Journal of Experimental Medicine·U D BajpaiH H Wortis
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Feb 22, 2001·The Journal of Experimental Medicine·T KaishoS Akira

❮ Previous
Next ❯

Citations

Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·Y Hosokawa
Mar 2, 2011·Cancer Causes & Control : CCC·Kristin L WhiteEllen L Goode
Jan 22, 2004·Current Opinion in Immunology·Anne PuelJean-Laurent Casanova
Mar 31, 2004·Trends in Immunology·Klaus-Dieter FischerThomas Wirth
Sep 13, 2005·Oncogene·Shao-Cong Sun, Shoji Yamaoka
Jan 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Y John ShyuChang-Deng Hu
Nov 23, 2005·The Journal of Experimental Medicine·Hisaaki ShinoharaTomohiro Kurosaki
Oct 15, 2013·The American Journal of Chinese Medicine·Hyo-Jin LeeYoung-Chae Chang
Mar 24, 2009·Annual Review of Immunology·Sivakumar Vallabhapurapu, Michael Karin
May 29, 2010·BMC Immunology·Hazem KhalafPer-Erik Olsson
Jun 27, 2008·PLoS Biology·Enrico Arpaia, Tak W Mak
Aug 11, 2012·PloS One·Siwei LiYuequan Shen
Nov 16, 2004·International Journal of Hematology·Yoshitaka Hosokawa, Masao Seto
Apr 16, 2013·Critical Reviews in Immunology·Sruti Krishna, Xiaoping Zhong
Aug 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Qiuyan Chen, A Catharine Ross
Sep 11, 2014·Journal of Clinical Immunology·Andrew W LindsleyAmal Assa'ad
Jun 25, 2014·Expert Opinion on Emerging Drugs·Sudy JahangiriPaul Barr
Apr 9, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Zunpeng ShuHaixue Kuang
Aug 25, 2012·Trends in Microbiology·Sonja Tattermusch, Charles R M Bangham
Jun 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jian Zhang
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kentaro KikuchiHiroshi Miyakawa
Aug 23, 2007·The British Journal of Dermatology·M Yaar, B A Gilchrest
Jul 1, 2010·Journal of Pineal Research·Sanseray da Silveira Cruz-MachadoRegina Pekelmann Markus
Oct 30, 2014·Photodermatology, Photoimmunology & Photomedicine·Flora PoonAnna L Chien
Sep 1, 2004·Biochemical and Biophysical Research Communications·Béla PappChristine Chomienne
Jun 13, 2006·The International Journal of Biochemistry & Cell Biology·Vinay Tergaonkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis